🇺🇸 FDA
Patent

US 9421250

Pathogenic phlebovirus isolates and compositions and methods of use

granted A61KA61K39/12

Quick answer

US patent 9421250 (Pathogenic phlebovirus isolates and compositions and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K39/12